Cargando…

Evaluating the Role of Morphological Parameters in the Prostate Transition Zone in PHI-Based Predictive Models for Detecting Gray Zone Prostate Cancer

BACKGROUND: The early detection of clinically significant prostate cancer (csPCa) through the integration of multidimensional parameters presents a promising avenue for improving survival outcomes for this fatal disease. This study aimed to assess the contribution of prostate transition zone (TZ) to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Yu-Hang, Shi, Yun-Tian, Sheng, Xu-Jun, Liao, Hai-Hong, Chen, Hao-Jie, Shi, Bo-Wen, Yu, Yong-Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588416/ https://www.ncbi.nlm.nih.gov/pubmed/37869472 http://dx.doi.org/10.1177/11795549231201122

Ejemplares similares

Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone
por: Xu, Bei, et al.
Publicado: (2021)

Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone
por: Liu, Junxiao, et al.
Publicado: (2020)

Improving the detection rate of prostate cancer in the gray zone of PI-RADS v2 and serum tPSA by using prostate-specific antigen–age volume
por: Lu, Yuan-Fei, et al.
Publicado: (2019)

Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
por: Lee, Jaegeun, et al.
Publicado: (2021)

Distribution of Neuroendocrine Cells in the Transition Zone of the Prostate
por: Kyoda, Yuki, et al.
Publicado: (2017)

Prostate zones and tumor morphological parameters on magnetic resonance imaging for predicting the tumor-stage diagnosis of prostate cancer
por: Xu, Shanshan, et al.
Publicado: (2023)

Morphologic perfusion patterns and PI-RADSv2.1 in transition zone prostate cancer
por: Garmer, M., et al.
Publicado: (2023)

Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone
por: Lee, Hakmin, et al.
Publicado: (2018)

Transition zone prostate cancer is associated with better clinical outcomes than peripheral zone cancer
por: Sato, Shun, et al.
Publicado: (2020)

Classification of Prostate Transitional Zone Cancer and Hyperplasia Using Deep Transfer Learning From Disease-Related Images
por: Hu, Bo, et al.
Publicado: (2021)

Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue
por: Deb, Subrata, et al.
Publicado: (2021)

Do prostate-specific antigen parameters have a similar role in predicting prostate cancer regardless of serum testosterone levels in men with gray-zone prostate-specific antigen levels?
por: Oh, Jeong Hoon, et al.
Publicado: (2022)

Transperineal Ultrasound-Guided 12-Core Prostate Biopsy: An Extended Approach to Diagnose Transition Zone Prostate Tumors
por: Yao, Ming-Hua, et al.
Publicado: (2014)

A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
por: Sönmez, Gökhan, et al.
Publicado: (2019)

MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies
por: Zhang, Li, et al.
Publicado: (2022)

Transition Zone Prostate Specific Antigen Density Improves Prostate Cancer Detection in Iranian Men
por: Nowroozi, Mohammadreza, et al.
Publicado: (2015)

Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI
por: Bao, Jie, et al.
Publicado: (2017)

“Textural analysis of multiparametric MRI detects transition zone prostate cancer”
por: Sidhu, Harbir S., et al.
Publicado: (2016)

Transitional Zone Index and Intravesical Prostatic Protrusion in Benign Prostatic Hyperplasia Patients: Correlations according to Treatment Received and Other Clinical Data
por: Huang, Tao, et al.
Publicado: (2012)

Establishment of two new predictive models for prostate cancer to determine whether to require prostate biopsy when the PSA level is in the diagnostic gray zone (4–10 ng ml(−1))
por: Liu, Jun, et al.
Publicado: (2019)

Low incidence of prostate cancer identified in the transition and anterior zones with transperineal biopsy
por: Danforth, Teresa L, et al.
Publicado: (2012)

Differences in the pathogenetic characteristics of prostate cancer in the transitional and peripheral zones and the possible molecular biological mechanisms
por: Yu, Xudong, et al.
Publicado: (2023)

Effects of Dynamic Contrast Enhancement on Transition Zone Prostate Cancer in Prostate Imaging Reporting and Data System Version 2.1
por: Zhang, Jiahui, et al.
Publicado: (2023)

Development, comparison, and validation of four intelligent, practical machine learning models for patients with prostate-specific antigen in the gray zone
por: Liu, Taobin, et al.
Publicado: (2023)

Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate
por: Carlsson, Jessica, et al.
Publicado: (2013)

Logistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRI
por: Dikaios, Nikolaos, et al.
Publicado: (2014)

Root Apex Transition Zone As Oscillatory Zone
por: Baluška, František, et al.
Publicado: (2013)

Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone
por: Liu, Fei, et al.
Publicado: (2022)

Pancreatic neuroendocrine tumors: the basics, the gray zone, and the target
por: Kelgiorgi, Dionysia, et al.
Publicado: (2017)

The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer
por: Zheng, Song, et al.
Publicado: (2019)

Dataset of prostate MRI annotated for anatomical zones and cancer
por: Adams, Lisa C., et al.
Publicado: (2022)

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
por: Kang, Ho Won, et al.
Publicado: (2020)

Quantitative measurements of prostatic zones by MRI and their dependence on prostate size: possible clinical implications in prostate cancer
por: Sellers, Jake, et al.
Publicado: (2021)

Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma
por: Kim, Jung Jun, et al.
Publicado: (2019)

Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With “Gray-Zone PSA” and Inhibits Cancer Progression via Regulating Glycosylation
por: Zhang, Cong, et al.
Publicado: (2021)

Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA
por: Mello-Grand, Maurizia, et al.
Publicado: (2021)

Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone
por: Niu, Xiang-ke, et al.
Publicado: (2017)

Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors
por: Koo, Kyo Chul, et al.
Publicado: (2013)

The relationship of gray zone and infarct core in the Iceland MI study
por: Mehra, Vishal C, et al.
Publicado: (2016)

The gray zone squamous lesions: ASC-US / ASC-H
por: Kattoor, Jayasree, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_77mbqudpkoiuvmj16sbdajmina